Peritoneal Dialysis–Related Peritonitis and Kidney Transplant Outcomes

Importance: Peritoneal dialysis (PD) is a common dialysis modality before kidney transplant. Peritonitis, a major complication of PD, may be associated with adverse posttransplant outcomes. Objective: To examine the association between history of peritonitis and outcomes among patients undergoing PD followed by kidney transplant. Design, Setting, and Participants: This is a retrospective cohort study of the Australia and New Zealand Dialysis and Transplant Registry. Patients who initiated PD as first kidney replacement therapy and underwent kidney transplant during 2006 to 2024 were included and followed-up from transplant until death, loss to follow-up, or December 31, 2024. Exposures: History of peritonitis. Main Outcomes and Measures: The primary outcomes were biopsy-proven acute rejection, death-censored graft failure, and all-cause mortality. Time-to-event outcomes were evaluated using multivariable Cox proportional hazard regression models. Results: A total of 4957 patients (median [IQR] age, 52 [42-61] years; 2912 male [59%]) were included, with a median (IQR) follow-up duration of 6.0 (2.6-9.3) years. Patients with peritonitis (1483 patients [30%]) were more likely to have obesity, have a higher comorbidity burden with a history of smoking, longer dialysis duration, and prior treatment with continuous ambulatory PD. Multivariable Cox regression analyses showed that peritonitis history was associated with shorter time to graft failure (adjusted hazard ratio [aHR], 1.55; 95% CI, 1.26-1.90) and death (aHR, 1.25; 95% CI, 1.06-1.48), but not with acute rejection (aHR, 1.09; 95% CI, 0.94-1.25). These findings were consistent across inverse probability-weighted Cox regression analyses and Fine-Gray competing risk models. Patients with recent peritonitis (≤6 months before transplant) had significantly higher risks of acute rejection (aHR, 1.52; 95% CI, 1.22-1.88), graft failure (aHR, 2.28; 95% CI, 1.73-3.00), and death (aHR, 1.37; 95% CI, 1.04-1.80), compared with those without peritonitis history. These associations were not consistently observed among patients with more remote peritonitis. Furthermore, peritonitis resulting in transfer to hemodialysis was associated with increased risk of graft failure (aHR, 1.99; 95% CI, 1.49-2.67; reference, no peritonitis), whereas a more modest increase was observed in cases not requiring hemodialysis transfer (aHR, 1.40; 95% CI, 1.11-1.76; reference, no peritonitis). Conclusions and Relevance: These findings suggest that a history of peritonitis is associated with increased risks of graft failure and death after kidney transplant and highlight the importance of comprehensive pretransplant assessment and longitudinal risk stratification.

Authors

Institutions

Publication Details

Journal
JAMA Network Open
Published
2026-08-21
DOI
https://doi.org/10.1001/jamanetworkopen.2026.30144
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Peritoneal Dialysis–Related Peritonitis and Kidney Transplant Outcomes

Yeoungjee Cho, Na Jiang, Elizabeth G. Ryan, David W. Johnson et al.
JAMA Network Open
Renal Transplantation Outcomes and Treatments
article

Peritoneal Dialysis–Related Peritonitis and Kidney Transplant Outcomes

Yeoungjee Cho, Na Jiang, Elizabeth G. Ryan, David W. Johnson, Suetonia Green, Ryan GATELY, Matthew Tunbridge, Rachael Walker
article en

Abstract

Importance: Peritoneal dialysis (PD) is a common dialysis modality before kidney transplant. Peritonitis, a major complication of PD, may be associated with adverse posttransplant outcomes. Objective: To examine the association between history of peritonitis and outcomes among patients undergoing PD followed by kidney transplant. Design, Setting, and Participants: This is a retrospective cohort study of the Australia and New Zealand Dialysis and Transplant Registry. Patients who initiated PD as first kidney replacement therapy and underwent kidney transplant during 2006 to 2024 were included and followed-up from transplant until death, loss to follow-up, or December 31, 2024. Exposures: History of peritonitis. Main Outcomes and Measures: The primary outcomes were biopsy-proven acute rejection, death-censored graft failure, and all-cause mortality. Time-to-event outcomes were evaluated using multivariable Cox proportional hazard regression models. Results: A total of 4957 patients (median [IQR] age, 52 [42-61] years; 2912 male [59%]) were included, with a median (IQR) follow-up duration of 6.0 (2.6-9.3) years. Patients with peritonitis (1483 patients [30%]) were more likely to have obesity, have a higher comorbidity burden with a history of smoking, longer dialysis duration, and prior treatment with continuous ambulatory PD. Multivariable Cox regression analyses showed that peritonitis history was associated with shorter time to graft failure (adjusted hazard ratio [aHR], 1.55; 95% CI, 1.26-1.90) and death (aHR, 1.25; 95% CI, 1.06-1.48), but not with acute rejection (aHR, 1.09; 95% CI, 0.94-1.25). These findings were consistent across inverse probability-weighted Cox regression analyses and Fine-Gray competing risk models. Patients with recent peritonitis (≤6 months before transplant) had significantly higher risks of acute rejection (aHR, 1.52; 95% CI, 1.22-1.88), graft failure (aHR, 2.28; 95% CI, 1.73-3.00), and death (aHR, 1.37; 95% CI, 1.04-1.80), compared with those without peritonitis history. These associations were not consistently observed among patients with more remote peritonitis. Furthermore, peritonitis resulting in transfer to hemodialysis was associated with increased risk of graft failure (aHR, 1.99; 95% CI, 1.49-2.67; reference, no peritonitis), whereas a more modest increase was observed in cases not requiring hemodialysis transfer (aHR, 1.40; 95% CI, 1.11-1.76; reference, no peritonitis). Conclusions and Relevance: These findings suggest that a history of peritonitis is associated with increased risks of graft failure and death after kidney transplant and highlight the importance of comprehensive pretransplant assessment and longitudinal risk stratification.

JAMA Network OpenVol. 9(8)
University of Auckland (NZ), Renji Hospital (CN), Princess Alexandra Hospital (AU), Auckland University of Technology (NZ), Kidney Health Australia (AU), Monash University (AU), University of Otago (NZ)
Good health and well-being
Openalex Percentile: Top 8%
Renal Transplantation Outcomes and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.